Elevated level of Vimentin has been detected in aggressive epithelial cancers, and is closely associated with an increased likelihood of metastasis and poor prognosis across various types of cancers, including NPC [36–38]. This evidence concerns the gene VIM and nasopharyngeal carcinoma.